TrialJournal of translational medicine2009

Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma.

Howard L Kaufman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.